bexarotene has been researched along with genistein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco-Gandía, M; Bonet-Costa, V; Borras, C; Garcia-Tarraga, P; Garcia-Verdugo, JM; Herranz-Pérez, V; Inglés, M; Mas-Bargues, C; Miñarro, J; Rodriguez-Arias, M; Viña, J | 1 |
1 other study(ies) available for bexarotene and genistein
| Article | Year |
|---|---|
Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apolipoproteins E; Astrocytes; Avoidance Learning; Bexarotene; Brain; Cells, Cultured; Disease Models, Animal; Female; Genistein; Habituation, Psychophysiologic; Maze Learning; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Nootropic Agents; Olfactory Perception; Plaque, Amyloid; PPAR gamma; Recognition, Psychology; Tetrahydronaphthalenes | 2016 |